(Commercial Critique Paper)
In a 1,200-1,500-word paper:
1.Critique a TV or radio commercial, an Internet advertisement, or a print advertisement from a nonprofessional journal/magazine related to an FDA-regulated prescription drug for a gastrointestinal disorder.
2.Critique a TV or radio commercial, an Internet advertisement, or a print advertisement from a nonprofessional journal/magazine related to a non-FDA-regulated over-the-counter medication/herbal for a gastrointestinal (GI) disorder.
Include a description of the pathophysiology of the GI disorder and how the medication/herbal alters that pathophysiology.
Compare and contrast the two commercials, including their stated use of medication/herbal, patient safety issues, analysis of company claims for any drug benefits. Substantiate your thoughts and ideas with evidence-based research/articles.
Prepare this assignment according to the APA guidelines found in the APA Style Guide, located in the Student Success Center. An abstract is not required.
Expert Solution Preview
The following assignment requires a critique of advertisements for medications geared towards gastrointestinal disorders. One advertisement will relate to a FDA-regulated prescription drug, while the other will pertain to a non-FDA regulated over-the-counter medication or herb. The critique will take into consideration the pathophysiology of the gastrointestinal disorder and how the medication/herb alters that pathophysiology. It will also compare and contrast the two advertisements in terms of their stated use of medication/herb, patient safety issues, and analysis of company claims for any drug benefits.
1) Critique of a TV or Radio Commercial, Internet Advertisement, or Print Advertisement from a Nonprofessional Journal/Magazine Related to an FDA-Regulated Prescription Drug for a Gastrointestinal Disorder.
The advertisement being critiqued is for a FDA-regulated prescription drug to treat the symptoms of irritable bowel syndrome (IBS), a common gastrointestinal disorder characterized by diarrhea, constipation, bloating, and abdominal pain. The medication being advertised is approved to alleviate only the diarrhea-predominant form of IBS. The commercial showcases the difficulties that individuals with IBS face in performing daily activities due to their symptoms. It then highlights the role of the medication in offering relief from the symptoms of IBS.
The company claims that the medication lessens the frequency and severity of IBS diarrhea, thus allowing individuals with IBS to return to their daily routines. However, it fails to mention that the medication is not effective in treating the constipation-predominant form of IBS. It also does not highlight the common side effects of the medication, which include abdominal pain, nausea, and headache. Further research shows that the medication only offers relief for short-term use. Additionally, the advertisement does not mention other treatment strategies, such as dietary changes, behavioral therapies, or other medications that can be used to alleviate the symptoms of IBS.
2) Critique of a TV or Radio Commercial, Internet Advertisement, or Print Advertisement from a Nonprofessional Journal/Magazine Related to a Non-FDA-Regulated Over-the-Counter Medication/Herb for a Gastrointestinal (GI) Disorder.
The advertisement being critiqued is for a non-FDA regulated over-the-counter medication marketed to treat acid reflux, a common GI disorder characterized by regurgitation of stomach contents into the esophagus causing heartburn. The commercial claims that the medication is an effective remedy for acid reflux, and is backed by scientific research.
However, the commercial does not clearly mention how the medication alters the pathophysiology of acid reflux. Further research shows that the medication works by neutralizing stomach acid, which can result in long-term complications if used regularly. These include increased risk of infections, nutrient deficiencies, and chronic kidney disease. The advertisement also fails to mention the importance of lifestyle changes, such as dietary adjustments, weight loss, smoking cessation, and exercise in managing acid reflux.
Comparison and Contrast of the Two Advertisements:
Both advertisements make claims to a growing market of gastrointestinal disorders, highlighting the need for effective treatments. However, the FDA-regulated prescription drug advertisement makes clear the limitations of the medication and the importance of consulting a healthcare provider while taking the medication. This contrasts with the non-FDA regulated over-the-counter medication advertisement, which focuses solely on the effectiveness of the medication and does not provide information about potential side effects or the need for long-term lifestyle changes.
Both advertisements fail to provide overarching information about the full range of treatment strategies that are available for the respective gastrointestinal disorders. Further research shows that lifestyle modifications, such as diet changes or physical exercise, can alleviate the symptoms of both IBS and acid reflux.
Substantiated by evidence-based research and articles, it is important for the advertisements for gastrointestinal medications to include essential information such as side effects, limitations, and efficacy in order to avoid any harm to patients. At the same time, it is crucial for individuals to always seek medical advice for medical conditions.